Abstract
C22H22O7, monoclinic, P21/n (no. 14), a = 7.8761(5) b = 17.0563(11) Å, c = 14.0504(10) Å, β = 95.563(4)°, V = 1878.6(2) Å3, Z = 4, Rgt(F) = 0.0504, wRref(F2) = 0.1475, T = 296(2) K.
The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Data collection and handling.
Crystal: | Orange needle |
Size: | 0.28 × 0.16 × 0.10 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 0.11 mm−1 |
Diffractometer, scan mode: | Bruker APEX-II, φ and ω |
θmax, completeness: | 25.2°, >99 % |
N(hkl)measured, N(hkl)unique, Rint: | 27,359, 3,379, 0.032 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 2,895 |
N(param)refined: | 262 |
Programs: | Olex2, 1 , 2 SHELX 3 , 4 |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
C′ | 0.9980 (4) | 0.6155 (2) | 0.9957 (2) | 0.0858 (10) |
H′A | 1.047297 | 0.651414 | 1.043239 | 0.129* |
H′B | 0.989218 | 0.564510 | 1.023660 | 0.129* |
H′C | 1.069099 | 0.612608 | 0.944015 | 0.129* |
C1 | 0.4512 (2) | 0.58886 (11) | 0.67536 (13) | 0.0351 (4) |
C1′ | 0.6007 (2) | 0.61573 (12) | 0.83728 (13) | 0.0416 (5) |
H1′ | 0.623467 | 0.666500 | 0.808417 | 0.050* |
C2 | 0.5419 (2) | 0.55900 (12) | 0.75849 (13) | 0.0373 (4) |
C2′ | 0.4650 (3) | 0.62708 (13) | 0.90612 (15) | 0.0472 (5) |
H2′A | 0.434597 | 0.576548 | 0.931229 | 0.057* |
H2′B | 0.363478 | 0.649448 | 0.871953 | 0.057* |
C3 | 0.5633 (2) | 0.47830 (12) | 0.76594 (13) | 0.0401 (5) |
C3′ | 0.5279 (3) | 0.68086 (14) | 0.98869 (16) | 0.0538 (6) |
H3′A | 0.538522 | 0.733988 | 0.965346 | 0.065* |
H3′B | 0.446172 | 0.681146 | 1.036088 | 0.065* |
C4A | 0.3950 (2) | 0.45750 (11) | 0.61627 (12) | 0.0336 (4) |
C4 | 0.4910 (2) | 0.42805 (12) | 0.69556 (14) | 0.0408 (5) |
H4 | 0.507332 | 0.374236 | 0.701933 | 0.049* |
C4′ | 0.6998 (3) | 0.65245 (15) | 1.03405 (15) | 0.0568 (6) |
H4′A | 0.685641 | 0.602444 | 1.065196 | 0.068* |
H4′B | 0.744542 | 0.689674 | 1.082309 | 0.068* |
C5 | 0.1290 (2) | 0.38437 (11) | 0.39539 (13) | 0.0379 (4) |
H5 | 0.142602 | 0.330695 | 0.404983 | 0.045* |
C5′ | 0.8260 (3) | 0.64332 (16) | 0.95887 (16) | 0.0588 (6) |
H5′ | 0.837899 | 0.694157 | 0.927692 | 0.071* |
C6 | 0.0295 (2) | 0.41244 (11) | 0.31630 (13) | 0.0376 (4) |
C7 | 0.0103 (2) | 0.49244 (12) | 0.30151 (13) | 0.0394 (4) |
H7 | −0.056141 | 0.510589 | 0.247702 | 0.047* |
C7′ | −0.0202 (4) | 0.65224 (14) | 0.26944 (17) | 0.0626 (7) |
H7′A | −0.021550 | 0.708506 | 0.270722 | 0.094* |
H7′B | 0.033403 | 0.634682 | 0.214736 | 0.094* |
H7′C | −0.135094 | 0.632850 | 0.265635 | 0.094* |
C8A | 0.1905 (2) | 0.51850 (10) | 0.44822 (12) | 0.0316 (4) |
C8 | 0.0888 (2) | 0.54549 (11) | 0.36576 (13) | 0.0351 (4) |
C8′ | −0.0350 (3) | 0.28468 (13) | 0.25559 (17) | 0.0585 (6) |
H8′A | −0.102603 | 0.259719 | 0.203655 | 0.088* |
H8′B | 0.083006 | 0.271843 | 0.252582 | 0.088* |
H8′C | −0.070863 | 0.266689 | 0.315215 | 0.088* |
C9A | 0.3751 (2) | 0.53886 (10) | 0.60356 (12) | 0.0325 (4) |
C9 | 0.2761 (2) | 0.57199 (11) | 0.51971 (12) | 0.0340 (4) |
C10A | 0.2077 (2) | 0.43694 (10) | 0.45993 (12) | 0.0325 (4) |
C10 | 0.3128 (2) | 0.40279 (11) | 0.54431 (14) | 0.0383 (4) |
O1 | 0.4377 (2) | 0.66714 (8) | 0.66738 (10) | 0.0502 (4) |
H1 | 0.381202 | 0.678234 | 0.617060 | 0.075* |
O2 | 0.6542 (2) | 0.44459 (10) | 0.84216 (10) | 0.0599 (5) |
H2 | 0.706939 | 0.478518 | 0.874100 | 0.090* |
O3 | 0.3278 (2) | 0.33212 (8) | 0.55354 (12) | 0.0627 (5) |
O4 | −0.0567 (2) | 0.36715 (8) | 0.24864 (10) | 0.0514 (4) |
O5 | 0.0723 (2) | 0.62367 (8) | 0.35400 (10) | 0.0534 (4) |
O6 | 0.2660 (2) | 0.64438 (8) | 0.51072 (10) | 0.0533 (4) |
O7 | 0.75589 (17) | 0.58746 (10) | 0.88715 (10) | 0.0525 (4) |
1 Source of material
The title compound is a natural product, which has been obtained by extraction and isolation from fungal fermentation products. 5 , 6
2 Experimental details
The structure was treated with the Olex2 crystallographic software package, 1 , 2 solved with the SHELXT structure solution program and refined with the SHELXL refinement package. 3 , 4 Carbon-bound hydrogen atoms were placed in calculated positions and refined with riding coordinates, with Uiso(H) fixed at 1.2 times of Ueq(C) (Tables 1 and 2).
3 Comment
The scaffold of 9,10-anthraquinone has attracted researchers’ interest due to its wide range of bio-activities, such as antitumor, antifungal, antidiabetic, anti-malarial, etc. 7 , 8 , 9 , 10 The title structure is composed of 9,10-anthraquinone and a pyranonyl group. The two moieties are not co-planar and have a C1⃛C2⃛C1′⃛C2′ torsion angle of 88.514°, which is different from previous reports. 11 The geometry of title structure was characterized with the bond angles and lengths. In particular, the bond angles for C7′⃛O5⃛C8, C8′⃛O4⃛C6, H1⃛O1⃛C1, H2⃛O2⃛C3, C1′⃛O7⃛C5′, C1′⃛C2′⃛O7′, O4⃛C6⃛C7 and O4⃛C6⃛C5 are 118.54(16)°, 117.91(16)°, 109.465°, 34.567°, 110.52(16)°, 114.58(16)° and 124.97(18)°, respectively. The bond lengths of C9⃛O6, C1⃛O1, C8⃛O5, C6⃛O4, C5⃛C10A, C10⃛O3, C1′⃛O7 and C12⃛C1′ are 1.243(2) Å, 1.343(2) Å, 1.348(2) Å, 1.355(2) Å, 1.379(3) Å, 1.217(2) Å, 1.432(2) Å and 1.509(3) Å, closely resembling to the reported ones. 12 Furthermore, there are two types of hydrogen bonds: O1⃛H1⃛O6, O2⃛H2⃛O7, with bond lengths of 1.768 Å and 1.903 Å, respectively. And it was further unequivocally secured that the stereo configurations of C1′ and C5′ are 1′ R and 5′ R. In the crystal structure, the three independent molecules form a trimer and the centroid-centroid distances of the π-π interactions are 3.493–3.594 Å, which is approximate to the reported. 13
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Conflict of interest: The authors declare no conflicts of interest regarding this article.
-
Research funding: This work was supported by the Scientific Research Personnel Training Program of Kangda College of Nanjing Medical University (No.KD2022KYRC007), Science & Technology Funds of Kangda College of Nanjing Medical University (No.KD2023KYJJ017&KD2023KYJJ019), the Science & Technology Funds of Lianyungang (No. SF2107 & JCYJ2320), and Jiangsu Province Drug Administration scientific research program projects (202416).
References
1. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. Olex2: a Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar
2. Bourhis, L. J.; Dolomanov, O. V.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. The Anatomy of a Comprehensive Constrained, Restrained Refinement Program for the Modern Computing Environment–Olex2 Dissected. Acta Crystallogr. 2015, 71, 59–75; https://doi.org/10.1107/s2053273314022207.Suche in Google Scholar
3. Sheldrick, G. M. A Short History of Shelx. Acta Crystallogr. 2008, 64, 112–122; https://doi.org/10.1107/s0108767307043930.Suche in Google Scholar PubMed
4. Sheldrick, G. M. Crystal Structure Refinement with Shelxl. Acta Crystallogr. 2015, 71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar
5. Holker, J. S. E.; Kagal, S. A.; Mulheirn, L. J.; White, P. M. Some New Metabolites of Aspergillus Vericolor and a Revised Structure for Averufin. Chem. Commun. 1966, 24, 911–913; https://doi.org/10.1039/c1966000911b.Suche in Google Scholar
6. Li, J.; Yang, X.; Lin, Y. Y.; Yun, J.; Lu, Y. J.; Zhu, X.; Li, J.; Li, M. F.; Lin, Y. C.; He, J. G.; Liu, L. Meroterpenes and Azaphilones from Marine Mangrove Endophytic Fungus Penicillium 303#. Fitoterapia 2014, 97, 241–246; https://doi.org/10.1016/j.fitote.2014.06.011.Suche in Google Scholar PubMed
7. Shrestha, J. P.; Subedi, Y. P.; Chen, L.; Chang, C.-W. T. A Mode of Action Study of Cation Anthraquinone Analogs: a New Class of Highly Potent Anticancer Agents. MedChemComm 2015, 6, 2012–2022; https://doi.org/10.1039/c5md00314h.Suche in Google Scholar
8. Wuthi-udomlert, M.; Kupittayanant, P.; Gritsanapan, W. In Vitro Evaluation of Antifungal Activity of Anthraquinone Derivatives of Senna alata. J. Health Res 2010, 24, 117–122.Suche in Google Scholar
9. Sang, Z. C.; Lee, S. O.; Jang, K. U.; Chung, S. H.; Sang, H. P.; Kang, H. C.; Yang, E. Y.; Cho, H. J.; Kang, R. L. Antidiabetic Stilbene and Anthraquinone Derivatives from Rheum Undulatum. Arch. Pharm Res. 2005, 28, 1027–1030; https://doi.org/10.1007/bf02977396.Suche in Google Scholar
10. Widyawaruyanti, A.; Devi, A. P.; Fatria, N.; Tumewu, L.; Hafid, A. F. In Vitro Antimalarial Activity Screening of Several Indonesian Plants Using HRP2 Assay. Int. J. Pharm. Pharm. Sci. 2014, 6, 125–128.Suche in Google Scholar
11. Obi, G.; Zamisa, S. J.; Heerden, F. R. Crystal Structure of 4-Methoxy-6-Phenyl-2h-Pyran-2-One, C12H10O3. Z. Kristallogr. N. Cryst. Struct. 2018, 233, 343–344; https://doi.org/10.1515/ncrs-2017-0068.Suche in Google Scholar
12. Chan, S.; Trotter, J. Aversin. Acta Cryst. 1995, C51, 272–274; https://doi.org/10.1107/s0108270194010589.Suche in Google Scholar
13. Kitamura, C.; L, S.; Takehar, M.; Inoue, Y.; Kawase, T. Crystal Structure of 1,4-Diethoxy-9,10–Anthraquinone. Acta Cryst. 2015, E71, o504–o505; https://doi.org/10.1107/S2056989015011901.Suche in Google Scholar PubMed PubMed Central
© 2024 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of N-(3-bromo-4-fluorophenyl)-N′-hydroxy-4-{[2-(4-methylphenyl)ethyl]amino}-1,2,5-oxadiazole-3-carboximidamide, C18H17BrFN5O2
- Synthesis and crystal structure of ethyl (2S,4aS,6aS,6bR,8aR,12aS,12bR,14bR,E)-10-(((3,4-dichlorobenzyl)oxy)imino)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylate
- The crystal structure of pyrazole nitrate
- Crystal structure of tetramethyl-bis(μ2-2-(2-hydroxy-3-methoxybenzylidene)-1-(6-(2-(2-hydroxy-3-methoxybenzylidene)hydrazine-1-carbonyl)picolinoyl)hydrazin-1-ido-κ4O,N,O′:O′)ditin(II) ─ ethanol (1/2), C54H62N10O14Sn2
- Crystal structure of catena-poly[μ3-iodido-(4-bromopyridine-κ1N)copper(I)], C5H4BrNCuI
- The crystal structure of cyclopentadienyl Co–P–C complexes by benzylideneacetone addition, C38H38CoO2P
- Synthesis and crystal structure of-(3S,10S,13S,17S)-N-(2-methoxyphenyl)-10,13-dimethyl-17-((R)-1-(phenylamino)ethyl)hexadecahydro-1H-cyclopenta[α]phenanthren-3-amine, C34H48N2O
- The crystal structure of (E)-3-((E)-3-(4-ethoxy-3-methoxyphenyl)-1-hydroxyallylidene) chroman-2,4-dione, C21H18O6
- The crystal structure of trans–L/D-[bis-(2-methyl-8-hydroxyquinoline-κ2 N,O) bis-(1,3,5-triaza-7-phosphaadamantane-κ2 P)cobalt(III)] tetrafluoroborate
- Crystal structure of 9-chloro-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C14H15ClN4
- Crystal structure of 7-(diethylamino)-3-(benzoyl)-2 H -chromen-2-one, C20H19NO3
- The crystal structure of 4–bromo-3,5-dinitropyrazole
- Crystal structure of 8-hydroxy-3,5,8a-trimethyl-7,8,8a,9-tetrahydronaphtho[2,3-b]furan-4,6-dione, C15H16O4
- Crystal structure of 5-hydroxy-3,5,8a-trimethyl-4a,5,6,7,8a,9-hexahydronaphtho[2,3-b]furan-4,8-dione, C15H18O4
- Synthesis and crystal structure of-(3S,10S,13S,17S)-N-(2-methoxyphenyl)-10,13-dimethyl-17-((R)-1-(p-tolylamino)ethyl)hexadecahydro-1H-cyclopenta[α]phenanthren-3-amine, C35H50N2O
- The crystal structure of catena-poly((μ2-1,3,5-tri(1H- imidazol-1-yl)benzene κ2N:N′)-bis(4-hydroxbenzoato-κ1O)-zinc(II) monohydrate), C29H24N6O7Zn
- Crystal structure of 2-(benzo[d]oxazol-2-yl)acetonitrile, C9H6N2O
- Crystal structure of 1,3-dihydroxy-6,8-dimethoxy-2-(6-methyltetrahydro-2Hpyran-2-yl)-4a,9a-dihydroanthracene-9,10-dione, C22H22O7
- The crystal structure of the double salt potassium 1-methylpiperazine-1,4-di-ium trinitrate, C5H14KN5O9
- Crystal structure of 5′-hydroxy-6′-methoxy-1′-methyl-2′,3′,8′,8a′-tetrahydro-1′H-spiro[cyclohexane-1,7′-cyclopenta[ij]isoquinoline]-2,5-dien-4-one, C18H19NO3
- The crystal structure of 1,1′-(2,3,5,6-tetramethylpyrazine-1,4-diyl)bis(ethan-1-one), C12H18N2O2
- Crystal structure of [μ2-piperazine-1,4-bis(2-hydroxypropanesulfonato-κ2O:O′)] bis(μ2-4,4′-trimethylenedipyridyl-κ2N:N′)disilver(I), C18H24AgN3O4S
- Crystal structure of bis ((1-((E)-((4-methoxyphenyl)imino)methyl)naphthalen-2-yl)oxy) copper(II), C36H28CuN2O4
- Synthesis and crystal structure of 6,6′-((1E,11E)-5,8-dioxa-2,11-diazadodeca-1,11-diene-1,12-diyl) bis(2,4-di-tert-butylphenol), C36H56N2O4
- The crystal structure of barium hexahydroxidoiridate(IV) dihydroxide, Ba2[Ir(OH)6](OH)2
- Crystal structure of cinnamoyl ferrocene, C19H16FeO
- Crystal structure of (E)-3-(4-butoxyphenyl)acryloylferrocene, C23H24FeO2
- Crystal structure of 7-(dimethylamino)-2-hydroxy-2-(trifluoromethyl)-2H-chromene-3-ethyl carboxylate, C15H16F3NO4
- The crystal structure of 1-phenylethan-1-aminium 4-hydroxy-3,5-dimethoxybenzoate C17H21NO5
- The crystal structure of 1,3,5-trichloro-2-nitrobenzene
- The crystal structure of tris(μ2-bromido)-bis(η6-p-cymene)-diosmium(II) tetrafluoroborate, C20H28BBr3F4Os2
- Crystal structure of new barium lithium manganese fluorides: Ba14Li1.87Mn14.13F68 with a Jarlite–related structure
- Crystal structure of (4-fluorobenzyl)triphenylphosphonium chloride, C25H21ClFP
- The crystal structure of calcitriol–chloroform (1/1), C27H44O3⋅CHCl3
- The crystal structure of (E)-1-((3)-nitrophenyl)pyren-3-(pyren-1-yl)prop-2-en-1-one, C25H15NO3
- Crystal structure of (E)-2-hydroxy-N′-(1-(4-hydroxyphenyl)propylidene)benzohydrazide, C16H16N2O3
- Crystal structure of (E)-(3-(thiophen-2-yl)acryloyl)ferrocene, C17H14FeOS
- Crystal structure of (E)-(3-(furan-2-yl)acryloyl)ferrocene, C17H14FeO2
- Synthesis and crystal structure poly[diaqua(μ3-3-(((7-hydroxy-3-(4-methoxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl) methyl)ammonio)propanoate-κ3 O:O′:O″) sodium(I)] monohydrate, C20H24NNaO12S
- Crystal structure of 9-methoxy-4-(2-methoxypyridin-3-yl)-5,6-dihydrobenzo[h]quinazolin-2-amine C19H18N4O2
- Synthesis and crystal structure of 4-(difluoromethyl)-1-methyl-N-(pyridin-3-yl)-1H-pyrazole-3-carboxamide hydrate, C11H12F2N4O2
- The crystal structure of caesalfurfuric acid B, C22H32O4
- The crystal structure of 2-bromo-2-(5-bromo-2-methyl-4-nitro-1H-imidazol-1-yl)-1-phenylethanone, C12H9Br2N3O3
- The crystal structure of bis{chlorido-[μ2-(1-oxidopyridin-2-yl)(pyridin-2-yl)amido-κ3 O,N, N′]copper(II)}, C20H16Cl2Cu2N6O2
- The crystal structure of 3-amino-2-formyl-1-phenyl-9,10-dihydrophenanthrene-4-carbonitrile, C22H16N2O
- The crystal structure of 1,1′-(2,5-dimethylpyrazine-1,4-diyl)bis(ethan-1-one), C10H14N2O2
- Crystal structure of 5′-(9-phenyl-9H-carbazol-3-yl)-[2,2′-bithiophene]-5-carbaldehyde, C27H17NOS2
- The crystal structure of the double salt dipyridin-1-ium bromide tribromide
- Crystal structure of (E)-(3-(3-methylthiophen-2-yl)acryloyl)ferrocene, C18H16FeOS
- Crystal structure of (E)-(3-(4-phenoxyphenyl)acryloyl)ferrocene, C25H20FeO2
- Crystal structure of (E)-(3-(3,4-dimethylphenyl)acryloyl)ferrocene, C21H20FeO
- Crystal structure of [(1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N‴)tetracyanidodiplatinum(II)] dimethyl sulfoxide solvate, C18H36N8O2Pt2S2
- Crystal structure of (4-ethoxybenzyl)triphenylphosphonium bromide ethanol solvate, C29H32BrO2P
- Crystal structure of (1-naphthalen-1-yl-methyl)triphenylphosphonium chloride ethanol solvate, C31H30ClOP
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N‴)platinum(II) bis[tribromido(dimethyl sulfoxide-κS)platinate(II)], C14H36Br6N4O2Pt3S2
- Crystal structure of (2-methylbenzyl)triphenylphosphonium chloride ethanol solvate, C28H30ClOP
- Crystal structure of bis(η2, σ1-8-methoxycyclooct-4-enyl)(μ2-1,4,8,11-tetraazacyclotetradecane-κ4 N, N′, N″, N‴)diplatinum(II) dibromide, C28H54Br2N4O2Pt2
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N‴)palladium(II) tetrabromidopalladate(II), C10H24Br4N4Pd2
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N‴)palladium(II) bis[trichlorido(dimethyl sulfoxide-κS)platinate(II)], C14H36Cl6N4O2PdPt2S2
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N‴)palladium(II) tetraiodidopalladate(II), C10H24I4N4Pd2
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of N-(3-bromo-4-fluorophenyl)-N′-hydroxy-4-{[2-(4-methylphenyl)ethyl]amino}-1,2,5-oxadiazole-3-carboximidamide, C18H17BrFN5O2
- Synthesis and crystal structure of ethyl (2S,4aS,6aS,6bR,8aR,12aS,12bR,14bR,E)-10-(((3,4-dichlorobenzyl)oxy)imino)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylate
- The crystal structure of pyrazole nitrate
- Crystal structure of tetramethyl-bis(μ2-2-(2-hydroxy-3-methoxybenzylidene)-1-(6-(2-(2-hydroxy-3-methoxybenzylidene)hydrazine-1-carbonyl)picolinoyl)hydrazin-1-ido-κ4O,N,O′:O′)ditin(II) ─ ethanol (1/2), C54H62N10O14Sn2
- Crystal structure of catena-poly[μ3-iodido-(4-bromopyridine-κ1N)copper(I)], C5H4BrNCuI
- The crystal structure of cyclopentadienyl Co–P–C complexes by benzylideneacetone addition, C38H38CoO2P
- Synthesis and crystal structure of-(3S,10S,13S,17S)-N-(2-methoxyphenyl)-10,13-dimethyl-17-((R)-1-(phenylamino)ethyl)hexadecahydro-1H-cyclopenta[α]phenanthren-3-amine, C34H48N2O
- The crystal structure of (E)-3-((E)-3-(4-ethoxy-3-methoxyphenyl)-1-hydroxyallylidene) chroman-2,4-dione, C21H18O6
- The crystal structure of trans–L/D-[bis-(2-methyl-8-hydroxyquinoline-κ2 N,O) bis-(1,3,5-triaza-7-phosphaadamantane-κ2 P)cobalt(III)] tetrafluoroborate
- Crystal structure of 9-chloro-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C14H15ClN4
- Crystal structure of 7-(diethylamino)-3-(benzoyl)-2 H -chromen-2-one, C20H19NO3
- The crystal structure of 4–bromo-3,5-dinitropyrazole
- Crystal structure of 8-hydroxy-3,5,8a-trimethyl-7,8,8a,9-tetrahydronaphtho[2,3-b]furan-4,6-dione, C15H16O4
- Crystal structure of 5-hydroxy-3,5,8a-trimethyl-4a,5,6,7,8a,9-hexahydronaphtho[2,3-b]furan-4,8-dione, C15H18O4
- Synthesis and crystal structure of-(3S,10S,13S,17S)-N-(2-methoxyphenyl)-10,13-dimethyl-17-((R)-1-(p-tolylamino)ethyl)hexadecahydro-1H-cyclopenta[α]phenanthren-3-amine, C35H50N2O
- The crystal structure of catena-poly((μ2-1,3,5-tri(1H- imidazol-1-yl)benzene κ2N:N′)-bis(4-hydroxbenzoato-κ1O)-zinc(II) monohydrate), C29H24N6O7Zn
- Crystal structure of 2-(benzo[d]oxazol-2-yl)acetonitrile, C9H6N2O
- Crystal structure of 1,3-dihydroxy-6,8-dimethoxy-2-(6-methyltetrahydro-2Hpyran-2-yl)-4a,9a-dihydroanthracene-9,10-dione, C22H22O7
- The crystal structure of the double salt potassium 1-methylpiperazine-1,4-di-ium trinitrate, C5H14KN5O9
- Crystal structure of 5′-hydroxy-6′-methoxy-1′-methyl-2′,3′,8′,8a′-tetrahydro-1′H-spiro[cyclohexane-1,7′-cyclopenta[ij]isoquinoline]-2,5-dien-4-one, C18H19NO3
- The crystal structure of 1,1′-(2,3,5,6-tetramethylpyrazine-1,4-diyl)bis(ethan-1-one), C12H18N2O2
- Crystal structure of [μ2-piperazine-1,4-bis(2-hydroxypropanesulfonato-κ2O:O′)] bis(μ2-4,4′-trimethylenedipyridyl-κ2N:N′)disilver(I), C18H24AgN3O4S
- Crystal structure of bis ((1-((E)-((4-methoxyphenyl)imino)methyl)naphthalen-2-yl)oxy) copper(II), C36H28CuN2O4
- Synthesis and crystal structure of 6,6′-((1E,11E)-5,8-dioxa-2,11-diazadodeca-1,11-diene-1,12-diyl) bis(2,4-di-tert-butylphenol), C36H56N2O4
- The crystal structure of barium hexahydroxidoiridate(IV) dihydroxide, Ba2[Ir(OH)6](OH)2
- Crystal structure of cinnamoyl ferrocene, C19H16FeO
- Crystal structure of (E)-3-(4-butoxyphenyl)acryloylferrocene, C23H24FeO2
- Crystal structure of 7-(dimethylamino)-2-hydroxy-2-(trifluoromethyl)-2H-chromene-3-ethyl carboxylate, C15H16F3NO4
- The crystal structure of 1-phenylethan-1-aminium 4-hydroxy-3,5-dimethoxybenzoate C17H21NO5
- The crystal structure of 1,3,5-trichloro-2-nitrobenzene
- The crystal structure of tris(μ2-bromido)-bis(η6-p-cymene)-diosmium(II) tetrafluoroborate, C20H28BBr3F4Os2
- Crystal structure of new barium lithium manganese fluorides: Ba14Li1.87Mn14.13F68 with a Jarlite–related structure
- Crystal structure of (4-fluorobenzyl)triphenylphosphonium chloride, C25H21ClFP
- The crystal structure of calcitriol–chloroform (1/1), C27H44O3⋅CHCl3
- The crystal structure of (E)-1-((3)-nitrophenyl)pyren-3-(pyren-1-yl)prop-2-en-1-one, C25H15NO3
- Crystal structure of (E)-2-hydroxy-N′-(1-(4-hydroxyphenyl)propylidene)benzohydrazide, C16H16N2O3
- Crystal structure of (E)-(3-(thiophen-2-yl)acryloyl)ferrocene, C17H14FeOS
- Crystal structure of (E)-(3-(furan-2-yl)acryloyl)ferrocene, C17H14FeO2
- Synthesis and crystal structure poly[diaqua(μ3-3-(((7-hydroxy-3-(4-methoxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl) methyl)ammonio)propanoate-κ3 O:O′:O″) sodium(I)] monohydrate, C20H24NNaO12S
- Crystal structure of 9-methoxy-4-(2-methoxypyridin-3-yl)-5,6-dihydrobenzo[h]quinazolin-2-amine C19H18N4O2
- Synthesis and crystal structure of 4-(difluoromethyl)-1-methyl-N-(pyridin-3-yl)-1H-pyrazole-3-carboxamide hydrate, C11H12F2N4O2
- The crystal structure of caesalfurfuric acid B, C22H32O4
- The crystal structure of 2-bromo-2-(5-bromo-2-methyl-4-nitro-1H-imidazol-1-yl)-1-phenylethanone, C12H9Br2N3O3
- The crystal structure of bis{chlorido-[μ2-(1-oxidopyridin-2-yl)(pyridin-2-yl)amido-κ3 O,N, N′]copper(II)}, C20H16Cl2Cu2N6O2
- The crystal structure of 3-amino-2-formyl-1-phenyl-9,10-dihydrophenanthrene-4-carbonitrile, C22H16N2O
- The crystal structure of 1,1′-(2,5-dimethylpyrazine-1,4-diyl)bis(ethan-1-one), C10H14N2O2
- Crystal structure of 5′-(9-phenyl-9H-carbazol-3-yl)-[2,2′-bithiophene]-5-carbaldehyde, C27H17NOS2
- The crystal structure of the double salt dipyridin-1-ium bromide tribromide
- Crystal structure of (E)-(3-(3-methylthiophen-2-yl)acryloyl)ferrocene, C18H16FeOS
- Crystal structure of (E)-(3-(4-phenoxyphenyl)acryloyl)ferrocene, C25H20FeO2
- Crystal structure of (E)-(3-(3,4-dimethylphenyl)acryloyl)ferrocene, C21H20FeO
- Crystal structure of [(1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N‴)tetracyanidodiplatinum(II)] dimethyl sulfoxide solvate, C18H36N8O2Pt2S2
- Crystal structure of (4-ethoxybenzyl)triphenylphosphonium bromide ethanol solvate, C29H32BrO2P
- Crystal structure of (1-naphthalen-1-yl-methyl)triphenylphosphonium chloride ethanol solvate, C31H30ClOP
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N‴)platinum(II) bis[tribromido(dimethyl sulfoxide-κS)platinate(II)], C14H36Br6N4O2Pt3S2
- Crystal structure of (2-methylbenzyl)triphenylphosphonium chloride ethanol solvate, C28H30ClOP
- Crystal structure of bis(η2, σ1-8-methoxycyclooct-4-enyl)(μ2-1,4,8,11-tetraazacyclotetradecane-κ4 N, N′, N″, N‴)diplatinum(II) dibromide, C28H54Br2N4O2Pt2
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N‴)palladium(II) tetrabromidopalladate(II), C10H24Br4N4Pd2
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N‴)palladium(II) bis[trichlorido(dimethyl sulfoxide-κS)platinate(II)], C14H36Cl6N4O2PdPt2S2
- Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N‴)palladium(II) tetraiodidopalladate(II), C10H24I4N4Pd2